EDITAS MEDICINE INC stock forecast: up to 13.54 USD EDIT stock price prognosis

STOCK

Forecast for Fri 19 May 2023 price 15.26

EDITAS MEDICINE INC stock price forecast for further price development up to 65.17% (time horizon: 1 day) and price target of 13.54 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) EDITAS MEDICINE INC share price prediction for 2023-05-19 with daily closed price projections

Key Facts

Symbol EDIT 

ISIN US28106W1036 

CUSIP 28106W103

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

News sentiment (0.71)

News <--> Close correlation for next day influence (-0.30)

Finance numbers

Revenue 91,508,000.0

Earnings per share -2.15

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 34.72/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
Prostatis Group LLC 2020-03-31 73750
American Portfolios Advisors 2022-03-31 1575
American Portfolios Advisors 2022-09-30 867
A - VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 26626
AdvisorNet Financial, Inc 2022-09-30 95

Fund ownership list is based on filling form information

Fund name Date Amount Profile
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 2022-12-31 1926 Long
JNL Series Trust 2022-12-31 19610 Long
JNL Series Trust 2022-12-31 1787 Long
JNL Series Trust 2022-12-31 71043 Long
LAZARD FUNDS INC 2022-12-31 3442 Long

Insider trading for EDITAS MEDICINE INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1874831 Eaton Bruce 2023-03-03 SALE Accept Reject Reject Accept
Assets / Liabilities

Bollinger Bollinger Bands for EDITAS MEDICINE INC can provide the information where the market is moving based on price information.

EDITAS MEDICINE INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns EDITAS MEDICINE INC.

On-Balance Volume information for EDITAS MEDICINE INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for EDITAS MEDICINE INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for EDITAS MEDICINE INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for EDITAS MEDICINE INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for EDITAS MEDICINE INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for EDITAS MEDICINE INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for EDITAS MEDICINE INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

Trend:
chart
NOVAVAX INC

News sentiment

Trend:
chart
Codiak BioSciences, Inc

Trend:
chart
KODIAK SCIENCES INC

Trend:
chart
TITAN PHARMACEUTICALS INC

EDITAS MEDICINE INC on Nasdaq

EDITAS MEDICINE INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-05-08 13.54 2023-03-25 03:41
2023-05-09 13.74 2023-03-25 03:41
2023-05-10 13.94 2023-03-25 03:41
2023-04-27 12.08 2023-03-25 03:41
2023-04-28 12.30 2023-03-25 03:41
2023-05-01 12.52 2023-03-25 03:41
2023-05-02 12.73 2023-03-25 03:41
2023-05-03 12.93 2023-03-25 03:41
2023-05-04 13.14 2023-03-25 03:41
2023-05-05 13.34 2023-03-25 03:41
2023-05-11 14.13 2023-03-25 03:41
2023-05-12 14.33 2023-03-25 03:41
2023-05-15 14.52 2023-03-25 03:41
2023-05-16 14.71 2023-03-25 03:41
2023-05-17 14.90 2023-03-25 03:41
2023-05-18 15.08 2023-03-25 03:41
2023-05-19 15.26 2023-03-25 03:41
2023-03-27 7.71 2023-03-25 03:41
2023-03-28 7.90 2023-03-25 03:41
2023-03-29 8.12 2023-03-25 03:41
2023-03-30 8.25 2023-03-25 03:41
2023-04-06 8.95 2023-03-25 03:41
2023-03-31 8.27 2023-03-25 03:41
2023-04-03 8.42 2023-03-25 03:41
2023-04-04 8.65 2023-03-25 03:41
2023-04-05 8.76 2023-03-25 03:41
2023-04-07 9.22 2023-03-25 03:41
2023-04-10 9.46 2023-03-25 03:41
2023-04-11 9.64 2023-03-25 03:41
2023-04-12 9.82 2023-03-25 03:41
2023-04-13 9.96 2023-03-25 03:41
2023-04-14 10.20 2023-03-25 03:41
2023-04-17 10.37 2023-03-25 03:41
2023-04-18 10.60 2023-03-25 03:41
2023-04-19 10.82 2023-03-25 03:41
2023-04-20 11.04 2023-03-25 03:41
2023-04-21 11.25 2023-03-25 03:41
2023-04-24 11.46 2023-03-25 03:41
2023-04-25 11.68 2023-03-25 03:41
2023-04-26 11.89 2023-03-25 03:41

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.